LOS ANGELES (April 30, 2015) - Preparing to face off for a thrilling Amgen Tour of California Invitational Time Trial at Big Bear Lake on Friday, May 15, is the strongest assembly of women cyclists in race history.
The roster of the fifth annual women's Invitational Time Trial includes previous Amgen Tour of California winners and World, National and Olympic Champions. Among the lineup of 23 will be Lisa Brennauer, reigning Individual and Team Time Trial World Champion (on her winning team were 2013 USA National Time Trial Champion Carmen Small and 2013 Amgen Tour of California Champion Evelyn Stevens, both of whom will be racing as well); two-time Amgen Tour of California Time Trial winner and Olympic Champion Kristin Armstrong; Amber Neben, who has held multiple national and world titles in road racing and time trial; para-cycling powerhouse Sarah Storey; and Tayler Wiles, who placed third in last year's Amgen Tour of California Time Trial.
"The Amgen Tour of California has always been a place where the best women in the world can come to race in an international forum. This year, the competition is steeper than ever," said Evelyn Stevens, who will be riding for Boels Dolmans Cycling Team.
Beginning at 11 a.m. on May 15, the Union Cycliste Internationale (UCI) sanctioned Amgen Tour of California Women's Invitational Time Trial empowered with SRAM will precede the men's Individual Time Trial (Stage 6). Empowered with SRAM, one of the founding partners of the Amgen Tour of California Women's Time Trial, the 15.1-mile race is ranked 1.1 by the UCI, the highest race classification behind a World Cup.
"I was planning to retire until I learned I had the opportunity to race in the 2015 Amgen Tour of California. It's a race worth sticking around for, and I'm thrilled to be a part of it," said BMW's p/b Happy Tooth Dental Rhae Shaw, who recently won the time trial in Big Bear Lake as part of the Redlands Bicycle Classic.
Competitors in the 2015 Amgen Tour of California Women's Invitational Time Trial empowered with SRAM follow:
|Maria Carla Alvarez||Xirayas de San Luis||ARG|
|Kristin Armstrong||TWENTY16 p/b Sho-Air||USA|
|Maddie Boutet||Team USA Cycling||USA|
|Laura Brown||UnitedHealthcare Pro Cycling Team||CAN|
|Karol Ann Canuel||Velocio-SRAM||CAN|
|Ana Teresa Casa||Mexico National Team||MEX|
|Jackie Crowell||Breakaway from Cancer||USA|
|Allie Dragoo||TWENTY16 p/b Sho-Air||USA|
|Jasmin Glaesser||Optum p/b Kelly Benefit Strategies||CAN|
|Megan Guarnier||Boels Dolmans Cycling Team||USA|
|Amber Neben||Visit Dallas Cycling p/b Noise4Good||USA|
|Rhae Shaw||BMW p/b Happy Tooth Dental||CAN|
|Carmen Small||TWENTY16 p/b Sho-Air||USA|
|Evelyn Stevens||Boels Dolmans Cycling Team||USA|
|Sarah Storey||Pearl Izumi Sports Tours International||GBR|
|Alison Tetrick||Optum p/b Kelly Benefit Strategies||USA|
|Linda Villumsen||UnitedHealthcare Pro Cycling Team||NZL|
|Emma White||Team USA Cycling||USA|
|Tara Whitten||Canada National Team||CAN|
Jackie Crowell, an Amgen Tour of California Ambassador, will be competing under the Breakaway from Cancer(r) banner in her first professional race since she was diagnosed with a brain tumor in 2013. Breakaway from Cancer is Amgen's initiative to raise awareness of the important resources available to people affected by cancer.
"I can't wait to get out on the course with all these amazing women. And it's especially poignant for me to be able to help bring attention to supporting cancer patients and their families through Breakaway from Cancer," said Jackie Crowell.
Some of the cyclists will seize the opportunity the race provides to prepare for the World Championships in Richmond this September. Junior riders like Emma White and Maddie Boutet with Team USA Cycling, both of whom are expected to ride at the World Championships, will get to test their mettle against some of the winningest time trialists in the sport.
"One of the founding goals of the Amgen Tour of California is to nurture the next generation of cyclists by giving them exposure to the best competition in the world. On occasion, that young hunger leads to very exciting and surprising turn of events," said Kristin Bachochin Klein, executive director of the Amgen Tour of California and senior vice president of AEG Sports. "That's the beauty of cycling - anything can happen. With the best field of women time trialists yet, we can't wait to see what is in store along the beautiful Big Bear Lake course."
At 6,752 feet, the fast and flat 15.1-mile course will feature one of the most beautiful lakes in California. Beginning in the Village in Big Bear Lake, the cyclists will wind counterclockwise around the lake via shore roads and neighborhoods, doubling back around the halfway point to finish on the 1,000-foot jetty near Stone Road.
For further information about the Amgen Tour of California and to experience the race like never before with VIP Access, please visit www.amgentourofcalifornia.com.
About the Amgen Tour of California
The Amgen Tour of California is a Tour de France-style cycling road race created and presented by AEG that challenges the world's top professional cycling teams to compete along a demanding course that traverses hundreds of miles of California's iconic highways, byways and coastlines each spring. The teams chosen to participate have included Olympic medalists, Tour de France contenders and World Champions. Amgen Tour of California is listed on the international professional cycling calendar (2 HC, meaning "beyond category"), awarding important, world-ranking points to the top finishers. More information is available at www.amgentourofcalifornia.com.
This year, the men's course will traverse more than 700 miles and wind through 13 host cities, including Sacramento, Nevada City, Lodi, San Jose, Pismo Beach, Avila Beach, Santa Barbara, Santa Clarita, Big Bear Lake, Ontario, Mt. Baldy, L.A. LIVE (Downtown Los Angeles) and Pasadena. The women's three-day stage race will travel more than 150 miles through South Lake Tahoe and Sacramento, followed by a 15-mile Invitational Time Trial in Big Bear Lake.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
AEG is one of the leading sports and entertainment presenters in the world. AEG, a wholly owned subsidiary of The Anschutz Company, owns or controls a collection of companies including facilities such as STAPLES Center, StubHub Center, Sprint Center, The O2, Nokia Theatre L.A. LIVE and Best Buy Theater Times Square; sports franchises including the Stanley Cup Champion LA Kings (NHL), two Major League Soccer franchises, two hockey franchises operated in Europe, management of privately held shares of the Los Angeles Lakers the Amgen Tour of California cycling road race; AEG Live, the organization's live-entertainment division, is a collection of companies dedicated to all aspects of live contemporary music performance, touring and a variety of programming and multi-media production. For more information, visit AEG today at www.aegworldwide.com.
Michael Roth, AEG
Eileen Tanner, Golin
Diana Valdez, Golin